Cell Culture Media Market Sales to Top US$ 5.6 Bn by 2031|Key Players- Thermo Fisher Scientific Inc., Merck KGaA and more

Cell Culture Media Market 2022

The global Cell Culture Media Market is estimated to reach US$ 5.6 Bn at a CAGR of 7.1% by the year 2031. With remote monitoring comes remote surgery. With digital twinning, this surgery becomes feasible. This could help in saving on prices of development of complex medical products, thereby improvising on time-to-market metric. This would be the thing with the healthcare vertical in the upcoming period.

According to a recent study by Persistence Market Research, the global cell culture media market is anticipated to witness high growth over the coming years. The market is predicted to grow from US$ 2.6 Bn in 2020 to over US$ 5.6 Bn by 2031. This reveals a CAGR of around 7.1% for the forecast period (2021-2031).

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/31338

Demand for cell culture media is increasing with rising production of biopharmaceuticals. Biopharmaceutical drugs are structurally similar to human compounds. This similarity in structure gives biopharmaceuticals the ability to cure diseases rather than only treat the symptoms. Also, biopharmaceuticals have fewer side effects because of their specificity, unlike conventional drugs that affect multiple systems. Biopharma is helping doctors in treating various diseases such as diabetes and cancer, because it allows clinicians to give specialized treatment to the specific medical problems of each patient.

With increasing demand for regenerative medicines, sale of cell culture media also increases. It is because regenerative medicine is that branch of medicine that develops methods to regrow, heal or replace injured or unhealthy cells, organs, and tissues.

Company Profiles:

Thermo Fisher Scientific Inc.
Merck KGaA
GE Healthcare
Lonza
Corning Incorporated
Irvine Scientific
STEMCELL Technologies Inc
PAN Biotech
MP Biomedicals, LLC
PromoCell GmbH
Becton, Dickinson and Company
Hi-Media Laboratories

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/31338

Key Takeaways from Market Study

By product, serum-free media holds a high share of 51.4% in 2021. Serum-free media is mainly used due to minimum risk of contamination.
By application, cancer research of cell culture media accounts for 43.7% market share.
By end user, biopharmaceutical companies account for 83.3% market share, indicating rising demand for stem cells and tissue engineering.
By region, North America holds the largest share of 32.6% of the global cell culture media market.

"Increasing production of antibodies for treatment of diseases and rising prevalence of cancer are expected to drive demand of cell culture media over the decade," says a Persistence Market Research analyst.

Who is Winning?

Some of the chief manufacturers of cell culture media are focusing on product launches, collaborations, and acquisitions for global expansion objectives, thereby enhancing their market presence.

In March 2021, PromoCell launched the improved 3rd generation melanocyte cell culture portfolio.
In May 2018, MP Biomedicals announced that it gained approval from the General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China (AQSIQ), to export bovine blood products to China.
In 2019, PAN Biotech announced its plan of expansion for export of fetal bovine serum globally.

Key market players covered in this research include GE Healthcare, Thermo Fisher Scientific, Merck KGaA, Lonza, Corning Incorporated, Irvine Scientific, STEMCELL Technologies Inc., and PAN Biotech.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/31338

Want More Valuable Insights?

Persistence Market Research brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global cell culture media Market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights into the cell culture media market. The market is segmented into five parts based on product (serum containing media, serum-free media, protein free media, and chemically defined media) based on application (cancer research, biopharmaceuticals, regenerative medicine & tissue engineering, stem cell technologies, and others) based on the end user (biopharmaceutical companies, clinical research organizations, and academic research centers), and across seven major regions.

Access Related Reports-

Diabetic Gastroparesis Market-

https://www.persistencemarketresearch.com/market-research/diabetic-gastroparesis-market.asp

Global diabetic gastroparesis treatment market is expected to register a CAGR of 4.1% over the forecast period and reach a market valuation of US$ 3,769.3 Mn by 2024.

Diabetic Nephropathy Market-

https://www.persistencemarketresearch.com/market-research/diabetic-nephropathy-market.asp

Global DMT market reached USD 2,093.5 million in 2014 and USD 2,929.8 million in 2020, growing at a CAGR of 5.8% from 2014 to 2020 - Persistence Market Research.

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.